Literature DB >> 12552056

The use of topiramate in refractory status epilepticus.

A R Towne1, L K Garnett, E J Waterhouse, L D Morton, R J DeLorenzo.   

Abstract

In cases of refractory status epilepticus (RSE) unresponsive to sequential trials of multiple agents, a suspension of topiramate administered via nasogastric tube was effective in aborting RSE, including one patient in a prolonged pentobarbital coma. Effective dosages ranged from 300 to 1,600 mg/d. Except for lethargy, no adverse events were reported.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552056     DOI: 10.1212/01.wnl.0000042783.86439.27

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 2.  The utility of EEG, SSEP, and other neurophysiologic tools to guide neurocritical care.

Authors:  Eric S Rosenthal
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.

Authors:  Erik K St Louis
Journal:  Pharmaceuticals (Basel)       Date:  2010-09-01

4.  Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality.

Authors:  Laurent Chevret; Beatrice Husson; Seraphin Nguefack; Astrid Nehlig; Viviane Bouilleret
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

5.  Status epilepticus.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 6.  Status epilepticus: an update.

Authors:  Panayiotis N Varelas; Marianna V Spanaki; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

Review 7.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

8.  Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.

Authors:  Chasity M Shelton; Elizabeth L Alford; Stephanie Storgion; James Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 9.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

10.  Topiramate in the treatment of partial and generalized epilepsy.

Authors:  Edward Faught
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.